CTI BioPharma Historical PE Ratio image   This CTIC PE ratio history page last updated 5/18/2023
CTI BioPharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2023
5/11/2023
8.94-0.10-0.40NA
Q4 2022
3/6/2023
4.83-0.14-0.56NA
Q3 2022
11/7/2022
4.97-0.13-0.52NA
Q2 2022
8/8/2022
7.06-0.21-0.84NA
Q1 2022
5/12/2022
3.66-0.37-1.48NA
Q4 2021
3/31/2022
4.67-0.38-1.52NA
Q3 2021
11/12/2021
2.67-0.26-1.04NA
Q2 2021
8/5/2021
2.53-0.21-0.84NA
Q1 2021
6/1/2021
2.50-0.23-0.92NA
Q4 2020
3/17/2021
3.30-0.20-0.80NA
Q3 2020
11/10/2020
3.31-0.15-0.60NA
Q2 2020
8/6/2020
1.33-0.19-0.76NA
Q1 2020
5/7/2020
1.03-0.20-0.80NA
Q4 2019
3/12/2020
0.83-0.14-0.56NA
Q3 2019
11/4/2019
0.80-0.17-0.68NA
Q2 2019
8/1/2019
0.75-0.19-0.76NA
Q1 2019
5/2/2019
0.98-0.19-0.76NA
Q4 2018
3/13/2019
1.000.010.0425.0
Q3 2018
11/1/2018
1.77-0.26-1.04NA
Q2 2018
8/2/2018
2.21-0.20-0.80NA
Q1 2018
5/3/2018
3.90-0.08-0.32NA
Q4 2017
3/7/2018
4.02-0.33-1.32NA
Q3 2017
11/6/2017
3.02-0.28-1.12NA
Q2 2017
8/3/2017
3.430.030.1228.6
Q1 2017
5/3/2017
4.18-0.71-2.84NA
Q4 2016
3/2/2017
4.49-0.23-0.92NA
Q3 2016
11/9/2016
4.10-1.00-4.00NA
Q2 2016
8/4/2016
3.70-0.70-2.80NA
Q1 2016
5/10/2016
4.400.100.4011.0
Q4 2015
2/16/2016
4.20-1.30-5.20NA
Q3 2015
11/5/2015
13.70-1.90-7.60NA
Q2 2015
8/6/2015
17.90-1.90-7.60NA
Q1 2015
5/6/2015
17.40-1.60-6.40NA
Q4 2014
3/12/2015
26.00-2.70-10.80NA
Q3 2014
10/29/2014
24.300.301.2020.2
Q2 2014
8/4/2014
25.10-1.90-7.60NA
Q1 2014
4/29/2014
30.70-2.00-8.00NA
Q4 2013
3/4/2014
38.100.803.2011.9
Q3 2013
10/30/2013
17.90-2.00-8.00NA
Q2 2013
7/31/2013
11.30-1.70-6.80NA
Q1 2013
5/2/2013
11.70-1.80-7.20NA
Q4 2012
2/28/2013
13.50-2.00-8.00NA
CTI BioPharma PE History Chart
PeriodPriceGAAPTTMPE
Q1 2023
5/11/2023
8.94-0.10-0.37NA
Q4 2022
3/6/2023
4.83-0.14-0.48NA
Q3 2022
11/7/2022
4.97-0.13-0.71NA
Q2 2022
8/8/2022
7.06-0.21-0.96NA
Q1 2022
5/12/2022
3.66-0.37-1.22NA
Q4 2021
3/31/2022
4.67-0.38-1.08NA
Q3 2021
11/12/2021
2.67-0.26-0.90NA
Q2 2021
8/5/2021
2.53-0.21-0.79NA
Q1 2021
6/1/2021
2.50-0.23-0.77NA
Q4 2020
3/17/2021
3.30-0.20-0.74NA
Q3 2020
11/10/2020
3.31-0.15-0.68NA
Q2 2020
8/6/2020
1.33-0.19-0.70NA
Q1 2020
5/7/2020
1.03-0.20-0.70NA
Q4 2019
3/12/2020
0.83-0.14-0.69NA
Q3 2019
11/4/2019
0.80-0.17-0.54NA
Q2 2019
8/1/2019
0.75-0.19-0.63NA
Q1 2019
5/2/2019
0.98-0.19-0.64NA
Q4 2018
3/13/2019
1.000.01-0.53NA
Q3 2018
11/1/2018
1.77-0.26-0.87NA
Q2 2018
8/2/2018
2.21-0.20-0.89NA
Q1 2018
5/3/2018
3.90-0.08-0.66NA
Q4 2017
3/7/2018
4.02-0.33-1.29NA
Q3 2017
11/6/2017
3.02-0.28-1.19NA
Q2 2017
8/3/2017
3.430.03-1.91NA
Q1 2017
5/3/2017
4.18-0.71-2.64NA
Q4 2016
3/2/2017
4.49-0.23-1.83NA
Q3 2016
11/9/2016
4.10-1.00-2.90NA
Q2 2016
8/4/2016
3.70-0.70-3.80NA
Q1 2016
5/10/2016
4.400.10-5.00NA
Q4 2015
2/16/2016
4.20-1.30-6.70NA
Q3 2015
11/5/2015
13.70-1.90-8.10NA
Q2 2015
8/6/2015
17.90-1.90-5.90NA
Q1 2015
5/6/2015
17.40-1.60-5.90NA
Q4 2014
3/12/2015
26.00-2.70-6.30NA
Q3 2014
10/29/2014
24.300.30-2.80NA
Q2 2014
8/4/2014
25.10-1.90-5.10NA
Q1 2014
4/29/2014
30.70-2.00-4.90NA
Q4 2013
3/4/2014
38.100.80-4.70NA
Q3 2013
10/30/2013
17.90-2.00-7.50NA
Q2 2013
7/31/2013
11.30-1.70NANA
Q1 2013
5/2/2013
11.70-1.80NANA
Q4 2012
2/28/2013
13.50-2.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree CTIC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
CTI BioPharma (CTIC) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CTKB PE Ratio History
CTLT PE Ratio History
CTMX PE Ratio History
CTSO PE Ratio History
CTXR PE Ratio History
CUE PE Ratio History
CUTR PE Ratio History
CVRX PE Ratio History
CVS PE Ratio History
CWBR PE Ratio History
How should the CTIC historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like CTI BioPharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CTIC Historical PE Ratio page.

What is the average historical PE for CTIC based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CTIC historical PE ratio using the annualized quarterly earnings method works out to 19.3.

What is the average historical PE for CTIC based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CTIC historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CTI BioPharma Historical PE Ratio information for CTI BioPharma' stock. The average CTIC historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 19.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CTIC historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CTIC historical PE result, against the recent PE: when this page was posted on 5/17/2023, the most recent closing price for CTIC had been 8.93, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CTIC PE on 5/17/2023 based on annualized quarterly EPS was 223.2. Based on CTIC's history, that recent PE is elevated relative to the historical average, with the recent PE 1056.5% higher than the historical average PE across our data set for CTI BioPharma.

For self directed investors doing their due diligence on CTIC or any other given stock, valuation analysis for CTIC can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate CTI BioPharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CTIC. Thanks for visiting, and the next time you need to research CTIC Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding SLGN, Top Ten Hedge Funds Holding FLGB, GHIX shares outstanding history.

 

CTI BioPharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.